However, the patient median overall survival of 12.7 months suggested that the persistent activation of the IFNγ signaling in GBM cells could have promoted the expression of immunosuppressive molecules that generated a negative feedback signal and reduced immune cell function. The gene discussed is IFNG; the disease is glioblastoma.